Immunic Inc. (IMUX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
- Moomoo launches paid trading toolkit called Moomoo Engine
- Angel founders transfer 10M+ super-voting shares to mission trust
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
